CARGO Therapeutics Inc. C...
(CRGX)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | - | - | - |
Cost of Revenue | 3.69M | 1.44M | 147.00K |
Gross Profit | -3.69M | -1.44M | -147.00K |
Operating Income | -96.71M | -34.77M | -5.98M |
Interest Income | - | - | - |
Pretax Income | -98.15M | -40.95M | -5.85M |
Net Income | -98.15M | -40.95M | -5.85M |
Selling & General & Admin | 17.23M | 5.40M | 1.52M |
Research & Development | 75.79M | 29.37M | 4.46M |
Other Expenses | - | -22.00K | 127.00K |
Operating Expenses | 96.71M | 34.77M | 5.98M |
Interest Expense | 1.60M | 4.94M | - |
Selling & Marketing Expenses | -3.69M | - | - |
Cost & Expenses | 96.71M | 34.77M | 5.98M |
Income Tax | - | 4.92M | 127.00K |
Shares Outstanding (Basic) | 41.21M | 19.23M | 19.47M |
Shares Outstanding (Diluted) | 41.21M | 19.23M | 19.47M |
EPS (Basic) | -2.38 | -2.13 | -0.3 |
EPS (Diluted) | -2.38 | -2.13 | -0.3 |
EBITDA | -93.02M | -33.35M | -5.70M |
Depreciation & Amortization | 3.69M | 1.44M | 147.00K |